{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:13:08Z","timestamp":1793113988907,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 113163"],"award-info":[{"award-number":["AI 113163"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AR007258"],"award-info":[{"award-number":["T32 AR007258"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI110495"],"award-info":[{"award-number":["U19 AI110495"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019896","name":"Ministrstvo za zdravje","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jaci.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T12:30:11Z","timestamp":1563193811000},"page":"968-981.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease"],"prefix":"10.1016","volume":"145","author":[{"given":"Emanuel","family":"Della-Torre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rigamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Perugino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Baghai-Sain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Rovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lanzillotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Mattoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Molineris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo A.","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.07.004_bib1","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.07.004_bib2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.07.004_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","article-title":"Fibrosis\u2014a lethal component of systemic sclerosis","volume":"10","author":"Ho","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaci.2019.07.004_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cei.12641","article-title":"Immunology of IgG4-related disease","volume":"181","author":"Della-Torre","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2019.07.004_bib5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.004_bib6","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1136\/annrheumdis-2014-205799","article-title":"B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease","volume":"74","author":"Della-Torre","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.004_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/cmi.2012.60","article-title":"Regulatory B cells in autoimmune diseases","volume":"10","author":"Yang","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaci.2019.07.004_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1523-1747.2003.12097.x","article-title":"Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis","volume":"120","author":"Sato","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.07.004_bib9","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","article-title":"Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group","volume":"74","author":"Jordan","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.004_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/resp.12214","article-title":"Rituximab in severe, treatment-refractory interstitial lung disease","volume":"19","author":"Keir","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.jaci.2019.07.004_bib11","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1182\/blood-2010-02-269894","article-title":"Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch","volume":"116","author":"Ding","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.07.004_bib12","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/ar4352","article-title":"B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis","volume":"15","author":"Fran\u00e7ois","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2019.07.004_bib13","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.07.004_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/annrheumdis-2016-209139","article-title":"Lesional CD4+ IFN-\u03b3+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis","volume":"76","author":"Maehara","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.004_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.004_bib16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/art.40469","article-title":"A CD8\u03b1- subset of CD4+ SLAMF7+ cytotoxic T cells is expanded in patients with IgG4-related disease and decreases following glucocorticoid treatment","volume":"70","author":"Della-Torre","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2019.07.004_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jaci.2019.07.004_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clim.2014.10.008","article-title":"Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease","volume":"156","author":"Furukawa","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.004_bib19","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.33386","article-title":"Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2019.07.004_bib20","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaci.2019.07.004_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cytogfr.2014.03.003","article-title":"PDGF receptor signaling networks in normal and cancer cells","volume":"25","author":"Demoulin","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaci.2019.07.004_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.004_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","article-title":"De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.004_bib24","first-page":"85","article-title":"Roles of plasmablasts and B cells in IgG4-related disease: implications for therapy and early treatment outcomes","volume":"401","author":"Lanzillotta","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaci.2019.07.004_bib25","first-page":"S159","article-title":"Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease","volume":"37","author":"Lanzillotta","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2019.07.004_bib26","first-page":"220","article-title":"Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse","volume":"3","author":"Lanzillotta","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2019.07.004_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jcb.10413","article-title":"Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell","volume":"88","author":"Kagan","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jaci.2019.07.004_bib28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/art.38277","article-title":"Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis","volume":"66","author":"Rimar","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2019.07.004_bib29","first-page":"747","article-title":"Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display","volume":"34","author":"Meyringer","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2019.07.004_bib30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jmcb\/mju039","article-title":"Lysyl oxidase promotes bleomycin-induced lung fibrosis through modulating inflammation","volume":"6","author":"Cheng","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.jaci.2019.07.004_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-018-0710-z","article-title":"Matrix stiffness: the conductor of organ fibrosis","volume":"20","author":"Santos","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jaci.2019.07.004_bib32","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800050","article-title":"The expansion in lymphoid organs of IL-41 BATF1 T follicular helper cells is linked to IgG4 class switching in\u00a0vivo","volume":"1","author":"Maehara","year":"2018","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.jaci.2019.07.004_bib33","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/ajh.24559","article-title":"Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: results of a phase II, multicenter noncomparative study","volume":"91","author":"Benhamou","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2019.07.004_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajh.24570","article-title":"A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)","volume":"92","author":"Michel","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2019.07.004_bib35","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/1352458518772748","article-title":"Efficacy of rituximab in refractory RRMS","volume":"25","author":"Durozard","year":"2019","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaci.2019.07.004_bib36","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.07.004_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.coi.2011.10.007","article-title":"The role of B cells in autoimmunity","volume":"23","author":"Pillai","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2019.07.004_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jnnp-2017-316519","article-title":"Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis","volume":"89","author":"Della-Torre","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaci.2019.07.004_bib39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2018.05.011","article-title":"Identification of galectin-3 as an autoantigen in patients with IgG4-related disease","volume":"143","author":"Perugino","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.004_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq0997","article-title":"Laminin 511 is a target antigen in autoimmune pancreatitis","volume":"10","author":"Shiokawa","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2019.07.004_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/1751-2980.12126","article-title":"Insulin-like growth factor binding protein-related protein 1 contributes to hepatic fibrogenesis","volume":"15","author":"Guo","year":"2014","journal-title":"J Dig Dis"},{"key":"10.1016\/j.jaci.2019.07.004_bib42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.RES.71.3.646","article-title":"Platelet-derived growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4","volume":"71","author":"Giannella-Neto","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/j.jaci.2019.07.004_bib43","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/annrheumdis-2014-205187","article-title":"IgG4-related midline destructive lesion","volume":"73","author":"Della-Torre","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.004_bib44","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1126\/science.1168755","article-title":"A self-regulatory system of interlinked signaling feedback loops controls mouse limb patterning","volume":"323","author":"B\u00e9nazet","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.07.004_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng1178","article-title":"Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning","volume":"34","author":"Khokha","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2019.07.004_bib46","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","article-title":"Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal","volume":"66","author":"Ikenaga","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.07.004_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41598-017-00270-0","article-title":"Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis","volume":"7","author":"Aumiller","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2019.07.004_bib48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.molcel.2013.10.015","article-title":"Regulation of heterochromatin transcription by Snail1\/LOXL2 during epithelial-to-mesenchymal transition","volume":"52","author":"Millanes-Romero","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.jaci.2019.07.004_bib49","doi-asserted-by":"crossref","first-page":"44988","DOI":"10.1038\/srep44988","article-title":"LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway","volume":"7","author":"Cuevas","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2019.07.004_bib50","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1309\/AJCPT5Y2JRIUUCUB","article-title":"Assessment of bone marrow fibrosis and angiogenesis in monitoring patients with multiple myeloma","volume":"137","author":"Babarovi\u0107","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaci.2019.07.004_bib51","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.168.6.2251","article-title":"Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta","volume":"168","author":"Sherry","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.07.004_bib52","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.07.004_bib53","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.179.3.881","article-title":"Eotaxin: a potent eosinophil chemoattractant cytokine detected in a\u00a0guinea\u00a0pig model of allergic airways inflammation","volume":"179","author":"Jose","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.07.004_bibE1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.004_bibE2","first-page":"259408","article-title":"Development of an IgG4-RD responder index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.jaci.2019.07.004_bibE3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaci.2019.07.004_bibE4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.jaci.2019.07.004_bibE5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.004_bibE6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/diabetes.51.1.55","article-title":"Human pancreatic islets produce and secrete MCP-1\/CCL2: relevance in human islet transplantation","volume":"51","author":"Piemonti","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jaci.2019.07.004_bibE7","doi-asserted-by":"crossref","first-page":"4.22.1","DOI":"10.1002\/0471142727.mb0422s107","article-title":"Preparation of Single-Cell RNA-Seq Libraries for Next Generation Sequencing","volume":"107","author":"Trombetta","year":"2014","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1016\/j.jaci.2019.07.004_bibE8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2019.07.004_bibE9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2019.07.004_bibE10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jaci.2019.07.004_bibE11","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.07.004_bibE12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.jaci.2019.07.004_bibE13","doi-asserted-by":"crossref","first-page":"8.13.1","DOI":"10.1002\/0471250953.bi0813s47","article-title":"Biological network exploration with Cytoscape 3","volume":"47","author":"Su","year":"2014","journal-title":"Curr Protoc Bioinformatics"},{"key":"10.1016\/j.jaci.2019.07.004_bibE14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/cyto.a.20052","article-title":"Microscopy-based multicolor tissue cytometry at the single-cell level","volume":"59","author":"Ecker","year":"2004","journal-title":"Cytometry A"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919309364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919309364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:26:06Z","timestamp":1758792366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919309364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0091674919309364"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.07.004","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}